These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11868297)

  • 1. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.
    Gholam PM; Kotler DP; Flancbaum LJ
    Obes Surg; 2002 Feb; 12(1):49-51. PubMed ID: 11868297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
    Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
    Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of wedge and needle hepatic biopsy in open bariatric surgery.
    Padoin AV; Mottin CC; Moretto M; Berleze D; Kupski C; Glock L; Reichel CL; da Silva VD; da Silva JB
    Obes Surg; 2006 Feb; 16(2):178-82. PubMed ID: 16469220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
    Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.
    de Almeida SR; Rocha PR; Sanches MD; Leite VH; da Silva RA; Diniz MT; Diniz Mde F; Rocha AL
    Obes Surg; 2006 Mar; 16(3):270-8. PubMed ID: 16545157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies.
    Papadia FS; Marinari GM; Camerini G; Murelli F; Carlini F; Stabilini C; Scopinaro N
    Obes Surg; 2004 Aug; 14(7):952-8. PubMed ID: 15329185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.
    Barker KB; Palekar NA; Bowers SP; Goldberg JE; Pulcini JP; Harrison SA
    Am J Gastroenterol; 2006 Feb; 101(2):368-73. PubMed ID: 16454845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity: risk factor for steatohepatitis and hepatic fibrosis].
    Poniachik J; Mancilla C; Contreras J; Csendes A; Smok G; Cavada G; Rojas J; Oksenberg D; Burdiles P; Maluenda F; Díaz JC
    Rev Med Chil; 2002 Jul; 130(7):731-6. PubMed ID: 12235896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and resolution of co-morbidities in super-obese patients remaining morbidly obese after Roux-en-Y gastric bypass.
    Bennett JC; Wang H; Schirmer BD; Northup CJ
    Surg Obes Relat Dis; 2007; 3(3):387-91. PubMed ID: 17533102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients.
    Dresel A; Kuhn JA; McCarty TM
    Am J Surg; 2004 Feb; 187(2):230-2; discussion 232. PubMed ID: 14769310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.
    Mottin CC; Moretto M; Padoin AV; Kupski C; Swarowsky AM; Glock L; Duval V; da Silva JB
    Obes Surg; 2005; 15(6):788-93. PubMed ID: 15978148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?
    Crespo J; Fernández-Gil P; Hernández-Guerra M; Cayón A; Mayorga M; Domínguez-Diez A; Fernández-Escalante JC; Pons-Romero F
    Obes Surg; 2001 Jun; 11(3):254-7. PubMed ID: 11433896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience.
    Suter M; Giusti V; Héraief E; Zysset F; Calmes JM
    Surg Endosc; 2003 Apr; 17(4):603-9. PubMed ID: 12582767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.